Affordable Access

deepdyve-link
Publisher Website

Erythropoietin-induced treatment costs in patients suffering from renal anemia - a comparison between biosimilar and originator drugs.

Authors
  • Hörbrand, F
  • Rottenkolber, D
  • Fischaleck, J
  • Hasford, J
Type
Published Article
Journal
Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany))
Publication Date
Nov 01, 2014
Volume
76
Issue
11
Identifiers
DOI: 10.1055/s-0033-1361111
PMID: 24493578
Source
Medline
License
Unknown

Abstract

A more common biosimilar prescription in renal anemia patients suffering from chronic kidney disease provides a noteworthy economic savings potential.

Report this publication

Statistics

Seen <100 times